Characterisation of proghrelin peptides in mammalian tissue and plasma

Characterisation of proghrelin peptides in mammalian tissue and plasma
复制标题

DOI:
10.1677/joe-06-0021
复制
发表时间:
2007-02-01
影响因子:
4
通讯作者:
Pemberton, Chris J.
Pemberton, Chris J.
中科院分区:
医学2区
文献类型:
--
作者:
Bang, Angela S.;Soule, Steven G.;Pemberton, Chris J.

文献摘要

被引文献

相似文献

Ghrelin是一种28个氨基酸的胃肽,来源于proghrelin(1-94),刺激GH释放,食欲和脂肪沉积。最近,已报道来源于促生长素释放肽(53-73)的肽-也称为obestatin -是大鼠中促生长素释放肽的生理拮抗剂。使用四种特异性RIA,我们提供了人血浆中促生长素释放肽(1-94)肽的第一个表征,它们通过代谢操作的调节及其在哺乳动物组织中的分布。通过HPLC/RIA测定,人血浆和大鼠血浆/胃中的ghrelin(1-28)免疫反应性(IR)由主要的脱辛酰基和次要的辛酰基化形式组成。人血浆ghrelin(1-28)IR通过食物摄入、口服葡萄糖和1 mg s.c.胰高血糖素给药。在大鼠中生长素释放肽(1-28)IR和前生长素释放肽(29-94)IR肽的分布表明胃和胃肠道含有最高量的肽。通过HPLC/RIA测定,人和大鼠血浆和大鼠胃提取物含有促生长素释放肽(29-94)样肽的主要IR峰,而未观察到obestatin IR。人血浆proghrelin(29-94)样IR与ghrelin(1-28)IR呈正相关,受食物摄入和口服葡萄糖的显著抑制,与ghrelin(1-28)IR共同与体重指数呈负相关。我们没有发现obestatin作为一种独特的内源性肽存在的证据。相反,我们的数据表明,源自促生长素释放肽(C-促生长素释放肽)的羧基末端的循环和储存肽在长度上与促生长素释放肽一致(29-94),并且至少在人中以与促生长素释放肽类似的方式响应代谢操纵(1-28)。
Ghrelin is a 28 amino acid stomach peptide, derived from proghrelin(1-94), that stimulates GH release, appetite and adipose deposition. Recently, a peptide derived from proghrelin(53-73) - also known as obestatin - has been reported to be a physiological antagonist of ghrelin in the rat. Using four specific RIAs, we provide the first characterisation of proghrelin(1-94) peptides in human plasma, their modulation by metabolic manipulation and their distribution in mammalian tissues. ghrelin(1-28) immunoreactivity (IR) in human plasma and rat plasma/stomach consisted of major des-octanoyl and minor octanoylated forms, as determined by HPLC/RIA. Human plasma ghrelin(1-28) IR was significantly suppressed by food intake, oral glucose and 1 mg s.c. glucagon administration. ghrelin(1-28) IR and proghrelin(29-94) IR peptide distributions in the rat indicated that the stomach and gastrointestinal tract contain the highest amounts of the peptides. Human and rat plasma and rat stomach extracts contained a major IR peak of proghrelin (29-94)-like peptide as determined by HPLC/RIA, whereas no obestatin IR was observed. Human plasma proghrelin(29-94)-like IR positively correlated with ghrelin(1-28) IR, was significantly suppressed by food intake and oral glucose and shared with ghrelin(1-28) IR a negative correlation with body mass index. We found no evidence for the existence of obestatin as a unique, endogenous peptide. Rather, our data suggest that circulating and stored peptides derived from the carboxyl terminal of proghrelin (C-ghrelin) are consistent in length with proghrelin(29-94) and respond to metabolic manipulation, at least in man, in similar fashion to ghrelin(1-28).